Quick Answer
AbCellera Biologics Inc. reported Shares Outstanding of 300.60 million shares for fiscal year 2025.
AbCellera Biologics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 300.60M | +1.6% |
| 2024 | 295.76M | +1.7% |
| 2023 | 290.82M | +1.4% |
| 2022 | 286.85M | +1.3% |
| 2021 | 283.26M | +5.1% |
| 2020 | 269.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 299.01M | +2.8% | +1.1% |
| June 30, 2025 | 295.76M | +1.7% | +0.0% |
| March 31, 2025 | 295.76M | +1.7% | +0.0% |
| December 31, 2024 | 295.76M | +0.2% | +1.7% |
| September 30, 2024 | 290.82M | +1.4% | +0.0% |
| June 30, 2024 | 290.82M | +1.4% | +0.0% |
| March 31, 2024 | 290.82M | +1.4% | -1.5% |
| December 31, 2023 | 295.16M | +1.9% | +2.9% |
- AbCellera Biologics Inc. showed an increase of +1.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, AbCellera Biologics Inc.’s shares outstanding has grown by 11.5% (from 269.50 million shares to 300.60 million shares).
- The most recent figure is from AbCellera Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: